Therefore, and in spite of displaying proapoptotic functions, p38 may constitute a target for prostate cancer treatment given its demonstrated contribution to some prostate cancer hallmarks, as androgen dependence and metastatic phenotype acquisition. This evidence concerns the gene MAPK1 and Familial prostate cancer.